Yu Luo

1.2k total citations
58 papers, 969 citations indexed

About

Yu Luo is a scholar working on Molecular Biology, Organic Chemistry and Cancer Research. According to data from OpenAlex, Yu Luo has authored 58 papers receiving a total of 969 indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Molecular Biology, 22 papers in Organic Chemistry and 11 papers in Cancer Research. Recurrent topics in Yu Luo's work include Cancer therapeutics and mechanisms (13 papers), Bioactive Compounds and Antitumor Agents (6 papers) and Synthesis and biological activity (6 papers). Yu Luo is often cited by papers focused on Cancer therapeutics and mechanisms (13 papers), Bioactive Compounds and Antitumor Agents (6 papers) and Synthesis and biological activity (6 papers). Yu Luo collaborates with scholars based in China, United States and Australia. Yu Luo's co-authors include Wei Lü, Qingqing Huang, Xu Song, Chuanfang Wu, Ling Li, Lan Yang, Linjiang Tong, Jia Li, Jianping Zuo and Wei Tang and has published in prestigious journals such as Nucleic Acids Research, Nature Communications and Hepatology.

In The Last Decade

Yu Luo

54 papers receiving 958 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yu Luo China 17 519 420 209 95 73 58 969
Prabhu Thirusangu India 20 430 0.8× 343 0.8× 164 0.8× 186 2.0× 59 0.8× 35 879
Xuejiao Song China 19 508 1.0× 150 0.4× 122 0.6× 219 2.3× 56 0.8× 37 943
Alexander M. Scherbakov Russia 19 633 1.2× 327 0.8× 208 1.0× 201 2.1× 25 0.3× 118 1.1k
Qiu Zhong United States 19 490 0.9× 427 1.0× 137 0.7× 220 2.3× 21 0.3× 39 1.0k
Haoliang Yuan China 21 697 1.3× 282 0.7× 58 0.3× 312 3.3× 96 1.3× 71 1.2k
Raju Mohan United States 19 647 1.2× 579 1.4× 71 0.3× 219 2.3× 58 0.8× 35 1.3k
Pierre Bischoff France 19 455 0.9× 220 0.5× 122 0.6× 336 3.5× 131 1.8× 39 1.0k
Yu-Shan Wu Taiwan 10 281 0.5× 199 0.5× 81 0.4× 185 1.9× 39 0.5× 10 644
Pijus K. Mandal United States 20 585 1.1× 473 1.1× 92 0.4× 514 5.4× 53 0.7× 31 1.3k
Chun Sing Li Canada 14 363 0.7× 321 0.8× 90 0.4× 80 0.8× 25 0.3× 19 709

Countries citing papers authored by Yu Luo

Since Specialization
Citations

This map shows the geographic impact of Yu Luo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yu Luo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yu Luo more than expected).

Fields of papers citing papers by Yu Luo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yu Luo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yu Luo. The network helps show where Yu Luo may publish in the future.

Co-authorship network of co-authors of Yu Luo

This figure shows the co-authorship network connecting the top 25 collaborators of Yu Luo. A scholar is included among the top collaborators of Yu Luo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yu Luo. Yu Luo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Luo, Yu, et al.. (2025). Expressive Vocabulary in Mandarin-Speaking Autistic, Developmentally Delayed, and Typically Developing Children: A Cross-sectional Study. Journal of Autism and Developmental Disorders. 1 indexed citations
2.
Wang, Haoyu, Wen Li, Yu Luo, et al.. (2025). Boosting contact electro-catalysis efficiency via nano-confinement effect in organic wastewater degradation. Nano Energy. 136. 110702–110702. 5 indexed citations
3.
Luo, Yu, Jie Geng, Jie Feng, et al.. (2024). A comprehensive review on the structure-activity relationships and applications of β-D-glucans. Bioactive Carbohydrates and Dietary Fibre. 32. 100460–100460. 3 indexed citations
4.
Lu, Qiuyu, et al.. (2020). Synthesis of 2-arylamino-5-formyl-pyrimidines from the bis(hexafluorophosphate) Arnold salt. Journal of Chemical Research. 44(9-10). 580–585.
5.
Wang, Xiaoyan, et al.. (2020). Advance in circular RNA modulation effects of heart failure. Gene. 763. 100036–100036. 14 indexed citations
6.
Wei, Lihua, Si Gao, Yating Yu, et al.. (2018). Homocysteine induces vascular inflammatory response via SMAD7 hypermethylation in human umbilical vein smooth muscle cells. Microvascular Research. 120. 8–12. 28 indexed citations
7.
Luo, Yu, et al.. (2017). MicroRNA-146a promotes the proliferation of rat vascular smooth muscle cells by downregulating p53 signaling. Molecular Medicine Reports. 16(5). 6940–6945. 9 indexed citations
8.
Shi, Lin, et al.. (2017). MiR-375: A prospective regulator in medullary thyroid cancer based on microarray data and bioinformatics analyses. Pathology - Research and Practice. 213(11). 1344–1354. 16 indexed citations
9.
Yu, Jiahui, et al.. (2015). Enhanced solubility, stability, and antitumor activity of the VESylated gemcitabine prodrug by co-assembly with TPGS. Journal of Controlled Release. 213. e48–e48. 4 indexed citations
10.
Zhang, Xuan, Jie Zhang, Linjiang Tong, et al.. (2013). The discovery of colchicine-SAHA hybrids as a new class of antitumor agents. Bioorganic & Medicinal Chemistry. 21(11). 3240–3244. 62 indexed citations
11.
Luo, Yu, et al.. (2013). Synthesis and in vitro cytotoxic evaluation of novel $$N$$ -(3,4,5-trimethoxyphenyl)pyridin-2( $$1H$$ )-one derivatives. Molecular Diversity. 17(3). 435–444. 4 indexed citations
12.
Luo, Yu, et al.. (2012). Synthesis and biological evaluation of new homocamptothecin analogs. European Journal of Medicinal Chemistry. 54. 281–286. 16 indexed citations
13.
Luo, Yu, Haomin Liu, Mingbo Su, et al.. (2011). Synthesis and biological evaluation of piperamide analogues as HDAC inhibitors. Bioorganic & Medicinal Chemistry Letters. 21(16). 4844–4846. 9 indexed citations
14.
Yang, Xiaoying, Yu Luo, Xin Li, et al.. (2011). Synthesis and Immunomodulating Activity of New Analogues of Fingolimod. Archiv der Pharmazie. 345(2). 93–100. 2 indexed citations
15.
Wang, Tao, Yu Luo, Qiao Wu, et al.. (2011). Aldo-keto reductase-7A protects liver cells and tissues from acetaminophen-induced oxidative stress and hepatotoxicity. Hepatology. 54(4). 1322–1332. 45 indexed citations
16.
Luo, Yu, Li Yang, Chunlan Feng, et al.. (2010). Design and synthesis of novel benzimidazole derivatives as inhibitors of hepatitis B virus. Bioorganic & Medicinal Chemistry. 18(14). 5048–5055. 48 indexed citations
17.
Luo, Yu, et al.. (2010). Synthesis and Anti‐Hepatitis B Virus Activity of a Novel Class of Thiazolylbenzimidazole Derivatives. Archiv der Pharmazie. 344(2). 78–83. 16 indexed citations
18.
Luo, Yu, et al.. (2010). Synthesis and in vitro cytotoxic evaluation of some thiazolylbenzimidazole derivatives. European Journal of Medicinal Chemistry. 46(1). 417–422. 32 indexed citations
19.
Zhang, Bo, Yu Luo, Qinjie Weng, et al.. (2008). CPT21, a novel compound with anti-proliferative effect against gastric cancer cell SGC7901. Investigational New Drugs. 26(6). 517–524. 3 indexed citations
20.
Huang, Weigang, Jingya Li, Wei Zhang, et al.. (2006). Synthesis of miltirone analogues as inhibitors of Cdc25 phosphatases. Bioorganic & Medicinal Chemistry Letters. 16(7). 1905–1908. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026